Lucentis and Temaz drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Lucentis (ranibizumab) and Temaz (temazepam). Common drug interactions include international normalised ratio increased among females and blood creatinine increased among males.

The phase IV clinical study analyzes what interactions people have when they take Lucentis and Temaz. It is created by eHealthMe based on reports of 52 people who take the same drugs from the FDA, and is updated regularly.

What is Lucentis?

Lucentis has active ingredients of ranibizumab. It is often used in macular degeneration. eHealthMe is studying from 25,647 Lucentis users. Check the latest studies of Lucentis.

What is Temaz?

Temaz has active ingredients of temazepam. It is often used in insomnia. eHealthMe is studying from 42,293 Temaz users. Check the latest studies of Temaz.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 27, 2026

52 people who take Lucentis and Temaz together, and have interactions are studied.

What are the common drug interactions of Lucentis and Temaz, by gender? *:

female:

International normalised ratio increased
Ischaemic stroke (stroke; caused by an interruption in the flow of blood to the brain)
Joint swelling
Lung consolidation (a condition whereby the lung tissues solidify because of the accumulation of solid and liquid material in the air spaces)
Multiple fractures
Nasopharyngitis (inflammation of the nasopharynx)
Osteoporosis (bones weak and more likely to break)
Pleural effusion (water on the lungs)
Pseudomonas infection (pseudomonas infection is caused by a bacterium, pseudomonas aeruginosa)
Pulmonary oedema (fluid accumulation in the lungs)

male:

Blood creatinine increased
Pneumonia
Renal failure acute (rapid kidney dysfunction)
Thrombocytopenia (decrease of platelets in blood)
Haemorrhage (bleeding)
Rash
Cardiac failure congestive
Gamma-glutamyltransferase increased
Glomerular filtration rate decreased
Respiratory failure (inadequate gas exchange by the respiratory system)

What are the common drug interactions of Lucentis and Temaz, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

Pneumonia
Dyspnoea (difficult or laboured respiration)
Rash vesicular (rash with a small bubble)
Renal failure acute (rapid kidney dysfunction)
Rash
Haemorrhage (bleeding)
Death
Ocular hyperaemia (an abnormally large amount of blood in eye)
Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
Hypertension (high blood pressure)

What are the existing conditions these people have? *

Age-Related Macular Degeneration: 10 people, 19.23%
Choroidal Neovascularisation (creation of new blood vessels in vascular layer of eye): 5 people, 9.62%

* Approximation only. Some reports may have incomplete information.

Do you take Lucentis and Temaz?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously